{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:44:32Z","timestamp":1769877872683,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.vaccine.2021.07.050","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T23:48:29Z","timestamp":1627861709000},"page":"5091-5094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Insurance reimbursements for recombinant zoster vaccine in the private sector"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8869-5561","authenticated-orcid":false,"given":"Andrew J.","family":"Leidner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-3156","authenticated-orcid":false,"given":"Zhaoli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-1107","authenticated-orcid":false,"given":"Tara C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-2174","authenticated-orcid":false,"given":"Yuping","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2021.07.050_b0005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.vaccine.2021.07.050_b0010","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"Morbidity Mortality Weekly Rep : Recommendations Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.050_b0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.07.050_b0020","unstructured":"Centers for Disease Control & Prevention. What everyone should know about Zostavax. Accessed August 1, 2020. https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/public\/zostavax\/index.html"},{"issue":"10","key":"10.1016\/j.vaccine.2021.07.050_b0025","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","article-title":"Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy","volume":"55","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2021.07.050_b0030","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2021.07.050_b0035","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.050_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.amepre.2020.01.017","article-title":"Shingles Vaccination of US Adults Aged 50\u201359 Years and\u2265 60 Years Before Recommendations for Use of Recombinant Zoster Vaccine","volume":"59","author":"Lu","year":"2020","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2021.07.050_b0045","unstructured":"Terlizzi EP, Black LI. Shingles vaccination among adults aged 60 and over: United States, 2018. 2020. NCHS Data Brief. July 2020."},{"key":"10.1016\/j.vaccine.2021.07.050_b0050","unstructured":"Centers for Disease Control Prevention. AdultVaxView. National Center for Immunizations and Respiratory Diseases. Accessed August 8, 2020. https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/data-reports\/index.html"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.050_b0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/21645515.2019.1637218","article-title":"The essential role of pharmacists facilitating vaccination in older adults: the case of Herpes Zoster","volume":"16","author":"Tak","year":"2020","journal-title":"Hum Vaccines Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.050_b0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.amepre.2018.05.011","article-title":"Clinicians\u2019 and pharmacists\u2019 reported implementation of vaccination practices for adults","volume":"55","author":"Lutz","year":"2018","journal-title":"Am J Prev Med"},{"issue":"8","key":"10.1016\/j.vaccine.2021.07.050_b0065","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.vaccine.2018.01.015","article-title":"Vaccine financing and billing in practices serving adult patients: a follow-up survey","volume":"36","author":"Lindley","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.050_b0070","doi-asserted-by":"crossref","first-page":"161-170","DOI":"10.7326\/M13-2332","article-title":"US physicians\u2019 perspective of adult vaccine delivery","volume":"160","author":"Hurley","year":"2014","journal-title":"Ann Intern Med"},{"issue":"42","key":"10.1016\/j.vaccine.2021.07.050_b0075","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1016\/j.vaccine.2019.08.056","article-title":"Analysis of the profitability of adult vaccination in 13 private provider practices in the United States","volume":"37","author":"Yarnoff","year":"2019","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2021.07.050_b0080","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1016\/j.vaccine.2019.08.002","article-title":"Ten years of experience with herpes zoster vaccine in primary care-how attitudes and practices have changed and what it may mean for a new zoster vaccine","volume":"37","author":"Guo","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.050_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vaccine.2018.11.055","article-title":"Review of the economic evidence presented to the United States Advisory Committee on Immunization Practices, 2012\u20132016","volume":"37","author":"Pike","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.07.050_b0090","unstructured":"Guidance for Health Economics Studies Presented to the Advisory Committee on Immunization Practices (ACIP), 2019 Update (Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases) (2019)."},{"key":"10.1016\/j.vaccine.2021.07.050_b0095","article-title":"Overview of two economic models that assess the cost-effectiveness of herpes zoster vaccinations","author":"Leidner","year":"2017","journal-title":"Centers Dis Control Prevent"},{"issue":"6","key":"10.1016\/j.vaccine.2021.07.050_b0100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/M18-2347","article-title":"A cost-effectiveness analysis of vaccination for prevention of herpes zoster and related complications: input for national recommendations","volume":"170","author":"Prosser","year":"2019","journal-title":"Ann Intern Med"},{"issue":"33","key":"10.1016\/j.vaccine.2021.07.050_b0105","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1016\/j.vaccine.2018.07.005","article-title":"Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States","volume":"36","author":"Curran","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.07.050_b0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.amepre.2019.03.011","article-title":"Insurance Reimbursements for Routinely Recommended Adult Vaccines in the Private Sector","volume":"57","author":"Tsai","year":"2019","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2021.07.050_b0115","unstructured":"Centers for Disease Control & Prevention. CDC Price List. https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html"},{"issue":"6","key":"10.1016\/j.vaccine.2021.07.050_b0120","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.vaccine.2018.12.045","article-title":"Provider time and costs to vaccinate adult patients: Impact of time counseling without vaccination","volume":"37","author":"Shen","year":"2019","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2021.07.050_b0125","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMsa022033","article-title":"Costs of health care administration in the United States and Canada","volume":"349","author":"Woolhandler","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2021.07.050_b0130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MLR.0000000000001117","article-title":"Estimating the costs and income of providing vaccination to adults and children","volume":"57","author":"Yarnoff","year":"2019","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2021.07.050_b0135","series-title":"Cost-effectiveness in health and medicine","author":"Neumann","year":"2016"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21009282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21009282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:37Z","timestamp":1759402777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21009282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":27,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0264410X21009282"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insurance reimbursements for recombinant zoster vaccine in the private sector","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}